ALKEME Acquires Axial Benefits Group
Accesswire
*ALKEME expands benefits offering with strategic acquisition in Massachusetts*
*LADERA RANCH, CA / ACCESSWIRE / May 16,..
Journal of Marketing
News and Video Search Results
News coverage
-
Rivers Agency Receives Multiple Honors at 30th Annual Communicator Awards
GlobeNewswire
-
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
-
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
ACN Newswire
-
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
GlobeNewswire
0 shares
1 views
You might like
Journal of Marketing media coverage
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
GlobeNewswire
Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment
CLEVELAND, May 14, 2024 (GLOBE..
-
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
Accesswire
-
Apple explains why it hasn’t released a touchscreen Mac (yet?)
9to5Mac
-
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
-
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
Advertisement
More coverage
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
GlobeNewswire
Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment
CLEVELAND, May 13, 2024 (GLOBE..
-
Lovesac Founder Shawn D. Nelson and Bestselling Author Gorick Ng to be Featured Speakers at FBLA National Leadership Conference
GlobeNewswire
-
Digital Journal sets sights on becoming Canada’s premier thought leadership platform with launch of Insight Forum
GlobeNewswire
-
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
GlobeNewswire
-
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
GlobeNewswire